BriaCell Therapeutics Corp. Logo

BriaCell Therapeutics Corp.

Develops off-the-shelf cellular immunotherapies for advanced breast, prostate, and lung cancers.

BCTX | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

BriaCell Therapeutics Corp. is a clinical-stage immuno-oncology company developing targeted cellular immunotherapies to activate the patient's immune system against cancer. Its lead candidate, Bria-IMT™, is a patented, off-the-shelf cell-based therapy in a pivotal Phase 3 study for advanced metastatic breast cancer. Bria-IMT™ has received FDA Fast Track designation and has shown efficacy in heavily pre-treated patients, including those with central nervous system metastases. The company is also advancing its next-generation Bria-OTS™ platform, which provides personalized, off-the-shelf treatments matched to a patient's HLA type. The Bria-OTS™ platform is being evaluated in a Phase 1/2 clinical trial for multiple cancers, including breast, prostate, and lung cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BriaCell Therapeutics Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BriaCell Therapeutics Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BriaCell Therapeutics Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Bestone.Com Co.,Ltd Logo
An online travel agency specializing in domestic and overseas cruise tours and tickets.
Japan 6577
BeyondSpring Inc. Logo
Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.
United States of America BYSI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.
United States of America BIAF
BIO-FD&C CO.,LTD. Logo
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea 251120
BioNexus Gene Lab Corp Logo
Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.
United States of America BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.
France ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
Belgium BIOS
BIOTECH Logo
Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.
Spain BST
BiotoxtechCo.,Ltd. Logo
A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.
South Korea 086040
Bolt Biotherapeutics, Inc. Logo
Developing immunotherapies that use antibody conjugates to help the immune system destroy cancer.
United States of America BOLT

Talk to a Data Expert

Have a question? We'll get back to you promptly.